A popular blood pressure medication has been recalled in the United States over concerns that it may be cross-contaminated with another drug.
Glenmark Pharmaceuticals Inc. has recalled more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets, sold under the brand name Ziac, after tests revealed the presence of ezetimibe, a drug used to treat high cholesterol.
The recall, published by the US Food and Drug Administration (FDA) on 1 December, was classified as Class III, meaning that exposure to the product is not likely to cause adverse health consequences.
The affected tablets come in 2.5mg and 6.25mg doses, with specific lot numbers and bottle sizes detailed in the recall notice. The expiry dates range from November 2025 to May 2026.
The FDA has not issued specific guidance for patients who may be taking the affected medication. Glenmark Pharmaceuticals has been contacted for comment.
